CR
Capital Research Global Investors disclosed a 5.4% stake in MDLN
Capital Research Global Investors reported owning 5.4% of Medline Inc. (MDLN) (47,768,233 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.